Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
about
Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiographyIntranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesRelease of PACAP-38 in episodic cluster headache patients - an exploratory study.Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseNovel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors.Cerebral hemodynamics in the different phases of migraine and cluster headache.Non-invasive methods for measuring vascular changes in neurovascular headaches.Reproducibility of migraine-like attacks induced by phosphodiesterase-3-inhibitor cilostazol.Laboratory tests of headache disorders - dawn of a new era?CGRP in human models of primary headaches.Functional Neuroimaging in Migraine: Chances and Challenges.Transmission pathways and mediators as the basis for clinical pharmacology of pain.Pathophysiology of Migraine: A Disorder of Sensory Processing.Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling.PACAP38: Emerging Drug Target in Migraine and Cluster Headache.Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521-1533.The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine.Cortical Spreading Depression Promotes Persistent Mechanical Sensitization of Intracranial Meningeal Afferents: Implications for the Intracranial Mechanosensitivity of MigraineTriptans and CGRP blockade - impact on the cranial vasculature.Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels.Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches.Neurovascular mechanisms of migraine and cluster headache.Human models of migraine - short-term pain for long-term gain.The relationship between migraine and rosacea: Systematic review and meta-analysis.No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients.PACAP-induced migraine: a possible CNS effect?Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.PACAP38 in human models of primary headaches.Targeted Orexin and Hypothalamic Neuropeptides for Migraine.PACAP and its role in primary headaches.PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma.Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias.PACAP38 and PAC receptor blockade: a new target for headache?Vascular Contributions to Migraine: Time to Revisit?
P2860
Q34501130-D8633BD1-1EDB-4D61-9F64-8C84780ECBAAQ35768362-9A68CA72-C24C-41EA-A066-6ED5BE43EBC3Q36090751-CCB7644C-6F0E-48B8-ABB2-8A0B80222362Q37208538-30317D29-90CF-42F0-A948-186BD7AA267BQ38254099-7EAC46BE-7AE0-440C-B248-F21DAA37939DQ38635129-D2DD26AF-1E16-4204-B7B8-B26D373A0755Q38646173-521C9412-91C8-4107-875B-4C09D2BC6859Q38693250-B37B4430-8A21-4632-AC81-82E828EA90F2Q38695434-A9B11B62-1BD3-40A5-A478-C6F344128EA5Q38784420-400BCCA8-846B-4EEA-9AC8-BB9C77929B1CQ38818899-A5E56525-E677-486E-9DB8-E2A860FDAE5BQ38870522-C917DCEA-5AF9-4AFA-8230-60B34A439031Q39127073-5DF0605E-4B20-499C-86DA-432BFE49E65DQ39155577-0FE001F2-3F9A-4F24-B07B-CDFCB0EFFE15Q39293515-B07EB27C-9FBE-4861-9441-D49A66776A8DQ40454917-7C93E98E-A42B-4255-8F8C-941190122E11Q40844180-AE0CBF91-9CB9-4181-91FE-64F86A0F959FQ40844188-96AF5881-C10E-431B-B5F6-A510FBDAC4EFQ41295027-92B6D2AD-FB06-476C-B63C-7B9F46F7FB5FQ41492299-127EF278-F57E-45D4-8736-214597A919A9Q42329951-E58B5B51-FA5D-42E7-8EBA-C535FEFAAD95Q42706186-23871248-4993-4DE9-9C39-B0FE4AFF306CQ47271955-8275E7D6-3656-46AE-9F07-67A39D403678Q47441037-1C6469F3-E925-4FD8-8EEC-BC4A9177CD84Q47676203-DD668A65-7809-4464-BCD4-C4013696C786Q47758217-2045AA37-76E7-44E3-8954-E048C0024AB4Q47912532-C4F56B88-2592-4701-8739-2F501D2E05FCQ47944255-B2A3AD9E-C00B-42D9-A130-ABDB00C8225CQ48041025-6523158A-D0AC-4725-BF3A-16BA3E941068Q48495487-FF806853-77B4-4CA9-8355-55CC42E7A108Q48660384-D2F521D5-EA5F-40AD-AA81-46851DC46A6AQ49721275-4A4AEDCF-9B22-4646-A258-B5FF9F6F9751Q49907816-651C20A0-9F23-4383-98CC-79B5317C988EQ50016389-684699FB-FD0E-4A3F-BCA5-085CFC002302Q52360955-E772A76F-A0F4-4CA2-80A6-1EE5E95E8A46Q52656846-8B8AEDD5-20CB-4C60-AA24-ECE6F9C5DA7CQ55004700-A6000D60-B806-4F91-831C-A95E33650826Q55290441-EACF06EC-4299-486E-B2C6-5849F7783FA4Q58797905-CC20D7BD-68BA-4C13-9519-94773FF2CC9AQ58801458-524FA1DD-EE2F-4635-99D7-EBEA288AE55E
P2860
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Investigation of the pathophys ...... ase-activating polypeptide-38.
@en
Investigation of the pathophys ...... ase-activating polypeptide-38.
@nl
type
label
Investigation of the pathophys ...... ase-activating polypeptide-38.
@en
Investigation of the pathophys ...... ase-activating polypeptide-38.
@nl
prefLabel
Investigation of the pathophys ...... ase-activating polypeptide-38.
@en
Investigation of the pathophys ...... ase-activating polypeptide-38.
@nl
P2093
P2860
P50
P356
P1433
P1476
Investigation of the pathophys ...... ase-activating polypeptide-38.
@en
P2093
Anders Hougaard
Arushma I Parvaiz
Elisabet Lundholm
Faisal Mohammad Amin
Henrik B W Larsson
Jan Fahrenkrug
Malene R Andersen
Mohammad S Asghar
Patrick J H de Koning
P2860
P304
P356
10.1093/BRAIN/AWT369
P407
P577
2014-02-05T00:00:00Z